118388-47-9

Basic information

• Product Name: (3S,4S)-3-Hydroxy-6-methyl-4-{2-[(S)-2-(3-methyl-butyrylamino)-3-phenyl-propane-1-sulfonyl]-3-phenyl-propionylamino}-heptanoic acid {(S)-1-[(S)-1-((S)-2-benzylcarbamoyl-1-hydroxy-ethyl)-3-methyl-butylcarbamoyl]-ethyl}-amide
• CAS NO: 118388-47-9
• Molecular Weight: 906.197
• Mol File: 118388-47-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (3S,4S)-3-Hydroxy-6-methyl-4-{2-[(S)-2-(3-methyl-butyrylamino)-3-phenyl-propane-1-sulfonyl]-3-phenyl-propionylamino}-heptanoic acid {(S)-1-[(S)-1-((S)-2-benzylcarbamoyl-1-hydroxy-ethyl)-3-methyl-butylcarbamoyl]-ethyl}-amide(CAS DataBase Reference)
• NIST Chemistry Reference: (3S,4S)-3-Hydroxy-6-methyl-4-{2-[(S)-2-(3-methyl-butyrylamino)-3-phenyl-propane-1-sulfonyl]-3-phenyl-propionylamino}-heptanoic acid {(S)-1-[(S)-1-((S)-2-benzylcarbamoyl-1-hydroxy-ethyl)-3-methyl-butylcarbamoyl]-ethyl}-amide(118388-47-9)
• EPA Substance Registry System: (3S,4S)-3-Hydroxy-6-methyl-4-{2-[(S)-2-(3-methyl-butyrylamino)-3-phenyl-propane-1-sulfonyl]-3-phenyl-propionylamino}-heptanoic acid {(S)-1-[(S)-1-((S)-2-benzylcarbamoyl-1-hydroxy-ethyl)-3-methyl-butylcarbamoyl]-ethyl}-amide(118388-47-9)

Safety Data

• Hazardous Substances Data: 118388-47-9(Hazardous Substances Data)

Upstream product

• 118387-87-4 2-[(S)-2-(3-Methyl-butyrylamino)-3-phenyl-propylsulfanyl]-3-phenyl-propionic acid tert-butyl ester 
• 118387-88-5 2-[(S)-2-(3-Methyl-butyrylamino)-3-phenyl-propylsulfanyl]-3-phenyl-propionic acid 
• 118387-86-3 2-((S)-2-Amino-3-phenyl-propylsulfanyl)-3-phenyl-propionic acid tert-butyl ester 
• 116264-32-5 (S)-2-amino-3-phenyl-1-propanethiol 
• 73058-30-7 (2S)-2-benzylazacyclopropane 
• 118388-46-8 (3S,4S)-3-Hydroxy-6-methyl-4-{2-[(S)-2-(3-methyl-butyrylamino)-3-phenyl-propylsulfanyl]-3-phenyl-propionylamino}-heptanoic acid {(S)-1-[(S)-1-((S)-2-benzylcarbamoyl-1-hydroxy-ethyl)-3-methyl-butylcarbamoyl]-ethyl}-amide 

Relevant articles and documents

Renin inhibitors containing isosteric replacements of the amide bond connecting the P3 and P2 sites

Renin inhibitors having 13 different isosteres connecting the P3 and P2 positions have been prepared. Synthetic routes and in vitro activity exhibited by these compounds are discussed. The two most potent compounds, 47 and 48, contai